跳至主要内容
临床试验/JPRN-UMIN000014391
JPRN-UMIN000014391已完成未知

Percutaneous Radiofrequency ablation for Pulmonary Metastasis from Colorectal Cancer: Phase II Clinical Trial - SCIRO-1401 study

Department of Radiology, Okayama University Medical School0 个研究点目标入组 45 人开始时间: 2014年6月27日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Lack of safe needle insertion path. 2)RFA is considered to be de hazardous because of critical organs close to the target lesion. 3)Presence of sever comorbidities. 4)Presence of uncontrolled other malignant diseases. 5)Presence of peritoneal dissemination and/or malignant ascites. 6)Fever higher than 38-Celsius degree. 7)Severe impairment of contralateral pulmonary function. 8)Presence of pulmonary hypertension. 9)Presence of interstitial pneumonia. 10)Usage of anticoagulants and antiplatelet agents. 11)Pregnant patients. 12)Patients who are considered to be unsuitable for inclusion by physicians due to other reasons.

研究者

发起方
Department of Radiology, Okayama University Medical School

相似试验